Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1166588 NEW YORK, NY

Position in ESPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
42,801
-71.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. ESPR ranks #54 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 42,801
2026-03-31 152,340
2025-12-31 213,665
2025-09-30 357,358
2025-06-30 22,569
2025-03-31 271,611
2024-12-31 153,212
2024-09-30 123,333
2024-06-30 48,811
2024-03-31 15,836
2023-12-31 23,858
2023-09-30 175,473
2023-06-30 196,663
2023-03-31 150,923
2022-12-31 69,309
2022-09-30 29,409
2022-06-30 24,227
2022-03-31 4,448
2021-12-31 5,802
2021-09-30 254,774
2021-06-30 1,020
2021-03-31 3,017
2020-12-31 2,954
2020-09-30 66,040
2020-06-30 4,448
2020-03-31 13,727